Pular para o conteúdo
Merck
Todas as fotos(7)

Documentos Principais

HPA040902

Sigma-Aldrich

Anti-MYO5B antibody produced in rabbit

enhanced validation

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Sinônimo(s):

Anti-Kiaa1119, Anti-Myosin vb

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
12352203
Número do Atlas de Proteínas Humanas:
NACRES:
NA.41

fonte biológica

rabbit

Nível de qualidade

conjugado

unconjugated

forma do anticorpo

affinity isolated antibody

tipo de produto de anticorpo

primary antibodies

clone

polyclonal

linha de produto

Prestige Antibodies® Powered by Atlas Antibodies

Formulário

buffered aqueous glycerol solution

reatividade de espécies

human

validação aprimorada

orthogonal RNAseq
independent
Learn more about Antibody Enhanced Validation

técnica(s)

immunohistochemistry: 1:200- 1:500

sequência de imunogênio

NLMKKELEEERSRYQNLVKEYSQLEQRYDNLRDEMTIIKQTPGHRRNPSNQSSLESDSNYPSISTSEIGDTEDALQQVEEIGLEKAAMDMTVFLK

nº de adesão UniProt

Condições de expedição

wet ice

temperatura de armazenamento

−20°C

modificação pós-traducional do alvo

unmodified

Informações sobre genes

human ... MYO5B(4645)

Descrição geral

Myosin VB (MYO5B) gene spanning 372,296 bases on genomic DNA with 42 exons is mapped to human chromosome 18q21.1. The gene codes for ubiquitously expressed myosin Vb protein. MYO5B contains N-terminal motor domain and C-terminal cargo-binding domain.

Imunogênio

myosin VB recombinant protein epitope signature tag (PrEST)

Aplicação

Anti-MYO5B antibody produced in rabbit has been used in immunostaining and western blot analysis.

Ações bioquímicas/fisiológicas

Myosin VB (MYO5B) acts as a motor for actin dependent organelle trafficking. Mutation or loss of MYO5B gene is associated with the development of an autosomal recessive syndrome, microvillus inclusion disease (MVID). Decreased expression of the protein has been observed in patients of gastric cancer. Therefore, MYO5B might act as a potential biomarker for gastric cancer. MYO5B interacts with Ras-related proteins 8a and 11a (Rab8a–Rab11a) component and stimulates stretch-induced exocytosis in bladder umbrella cells.

Características e benefícios

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Ligação

Corresponding Antigen APREST81706

forma física

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Informações legais

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Não está encontrando o produto certo?  

Experimente o nosso Ferramenta de seleção de produtos.

Código de classe de armazenamento

10 - Combustible liquids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Loss of MYO5B in mice recapitulates Microvillus Inclusion Disease and reveals an apical trafficking pathway distinct to neonatal duodenum.
Weis VG
Cellular and molecular gastroenterology and hepatology, 2(2), 131-157 (2016)
An overview and online
registry of microvillus
inclusion disease patients
and their MYO5B mutations
van der Velde KJ
Human Mutation, 34(12), 1597-1605 (2013)
Victoria G Weis et al.
Cellular and molecular gastroenterology and hepatology, 2(2), 131-157 (2016-03-29)
Inactivating mutations in MYO5B cause severe neonatal diarrhea in Microvillus Inclusion Disease. Loss of active MYO5B causes the formation of pathognomonic inclusions and aberrations in brush border enzymes. We developed three mouse models of germline, constitutively intestinal targeted and inducible
A Rab11a-Rab8a-Myo5B network promotes stretch-regulated exocytosis in bladder umbrella cells.
Khandelwal P
Molecular Biology of the Cell, 24(7), 1007-1019 (2013)
Inactivation of MYO5B promotes invasion and motility in gastric cancer cells.
Dong W
Digestive Diseases and Sciences, 57(5), 1247-1252 (2012)

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica